MTIM
ABBV icon

Marathon Trading Investment Management’s AbbVie ABBV Stock Holding History

Marathon Trading Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,700
Closed -$356K – 272
2025
Q1 		$356K Sell
1,700
-300
-15% -$58.3K 0.05% 171
2024
Q4 		$355K Buy
2,000
+400
+25% +$73.5K 0.02% 179
2024
Q3 		$316K Buy
+1,600
New +$299K 0.03% 178
2024
Q1 		– Sell
-2,200
Closed -$341K – 354
2023
Q4 		$341K Sell
2,200
-5,400
-71% -$787K 0.02% 236
2023
Q3 		$1.13M Buy
7,600
+1,900
+33% +$279K 0.09% 98
2023
Q2 		$768K Sell
5,700
-3,800
-40% -$557K 0.06% 107
2023
Q1 		$1.51M Buy
9,500
+6,600
+228% +$1.01M 0.11% 85
2022
Q4 		$469K Sell
2,900
-2,700
-48% -$414K 0.06% 135
2022
Q3 		$752K Sell
5,600
-4,800
-46% -$689K 0.07% 128
2022
Q2 		$1.59M Buy
10,400
+5,800
+126% +$886K 0.18% 101
2022
Q1 		$746K Buy
+4,600
New +$668K 0.06% 150
2021
Q1 		– Sell
-7,000
Closed -$750K – 390
2020
Q4 		$750K Buy
+7,000
New +$673K 0.04% 181
2015
Q1 		– Sell
-50,000
Closed -$3.25M – 463
2014
Q4 		$3.25M Buy
+50,000
New +$3.15M 0.05% 209

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Marathon Trading Investment Management's ABBV Position: Q3 2023 in Review

Marathon Trading Investment Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 1,000 shares — an estimated $147K sold.

Marathon Trading Investment Management first reported a position in ABBV in Q2 2019 and held it in 8 quarters. The position peaked at $1.18M in Q2 2019. 3,111 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Marathon Trading Investment Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Marathon Trading Investment Management sold 1,000 AbbVie shares in Q3 2023, an estimated $147K.
  • Marathon Trading Investment Management first reported a position in AbbVie in Q2 2019 and held it in 8 quarters.
  • Marathon Trading Investment Management's AbbVie position peaked at $1.18M in Q2 2019.
  • 3,111 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Marathon Trading Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.